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ABSTRACT
Mismatch repair is a highly conserved system that
ensures replication ®delity by repairing mispairs
after DNA synthesis. In humans, the two protein
heterodimers hMutSa (hMSH2-hMSH6) and hMutLa
(hMLH1-hPMS2) constitute the centre of the repair
reaction. After recognising a DNA replication error,
hMutSa recruits hMutLa, which then is thought to
transduce the repair signal to the excision machin-
ery. We have expressed an ATPase mutant of
hMutLa as well as its individual subunits hMLH1
and hPMS2 and fragments of hMLH1, followed by
examination of their interaction properties with
hMutSa using a novel interaction assay. We show
that, although the interaction requires ATP, hMutLa
does not need to hydrolyse this nucleotide to join
hMutSa on DNA, suggesting that ATP hydrolysis by
hMutLa happens downstream of complex formation.
The analysis of the individual subunits of hMutLa
demonstrated that the hMutSa±hMutLa interaction
is predominantly conferred by hMLH1. Further
experiments revealed that only the N-terminus of
hMLH1 confers this interaction. In contrast, only the
C-terminus stabilised and co-immunoprecipitated
hPMS2 when both proteins were co-expressed in
293T cells, indicating that dimerisation and stabil-
isation are mediated by the C-terminal part of
hMLH1. We also examined another human homo-
logue of bacterial MutL, hMutLb (hMLH1±hPMS1).
We show that hMutLb interacts as ef®ciently with
hMutSa as hMutLa, and that it predominantly binds
to hMutSa via hMLH1 as well.
INTRODUCTION
DNA mismatch repair (MMR) is a highly conserved system
which corrects base±base mismatches and insertion±deletion
loops arising during DNA replication (reviewed in 1±3). In
bacteria, the two protein dimers MutS and MutL constitute the
main components of the repair machinery, exerting mismatch
recognition and signalling repair initiation. Several eukary-
otic heterodimers have developed from these prokaryotic
homodimers. In humans, hMutSa (hMSH2-hMSH6), hMutSb
(hMSH2-hMSH3), hMutLa (hMLH1-hPMS2) and hMutLb
(hMLH1-hPMS1) were identi®ed, and mutations in their
genes (predominantly hMLH1 and hMSH2) segregate with
hereditary nonpolyposis colorectal cancer (HNPCC), a cancer
predisposition syndrome (4±7).
Although the repair reaction can be exerted in vitro with
protein extracts (8,9), its exact mechanism is still unknown.
While MutS and its eukaryotic counterparts are responsible for
mismatch recognition (10±13), the function of MutL proteins
is more dif®cult to characterise. They seem to couple
mismatch recognition to incision and removal of the nascent
DNA strand, followed by resynthesis, which completes the
repair reaction.
A major barrier for understanding the initiation of MMR is
the seemingly paradoxical interplay of mismatch binding and
ATP processing by MutS proteins. While ATP hydrolysis is
enforced in the presence of heteroduplex DNA (14,15), ATP
binding induces dissociation of MutS proteins from the
mismatch (16±20). This raises the question of how repair
can be accomplished when ATP hydrolysis, which is likely to
signal repair initiation, occurs after ATP binding has induced
MutS to leave the mismatched site. Two repair models resolve
this con¯ict by assuming that MutS proteins need to leave the
mismatched site in order to search for a strand discrimination
signal and to alert the excision machinery. Of these two
models, the translocation model assumes that the movement is
driven by ATP hydrolysis and serves to loop the faulty DNA
duplex prior to strand incision at the base of the arising loop
(17). In contrast, the molecular switch model proposes that
MutS forms a hydrolysis-independent sliding clamp on DNA
after ATP uptake, signalling the ®nding of a mismatch to
repair enzymes located elsewhere on the DNA duplex in a
manner similar to G-protein signalling (21,22). Another model
suggests that MutS proteins do not lose, but only reduce
af®nity to DNA after ATP binding, thereby verifying the
actual presence of the mismatch. This implies that binding to
the mismatch is maintained during repair initiation. Since this
model requires a bent DNA to enable MutS to contact the
mismatch as well as other proteins bound elsewhere on the
DNA duplex, it was referred to as the DNA bending model
(23,24).
MutL and its homologues can also hydrolyse ATP (25,26)
and bind DNA. Single-stranded DNA is preferred in short
substrates (27,28), while yeast MutLa has been found to bind
double-stranded DNA ef®ciently in a cooperative manner
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shown that hMutLa and hMutLb interact with hMutSa in an
ATP-dependent manner, and that this interaction is DNA
dependent (27,30,31). While ATP hydrolysis by MutL
proteins is essential for MMR (26,32±34), its role within the
repair reaction is still unclear. MutL and its eukaryotic
counterparts seem to signal mismatch recognition from MutS
to downstream proteins [e.g. MutH and UvrD in bacterial
MMR (35±37)]. Therefore, MutL proteins have been sug-
gested to be molecular matchmakers, coupling mismatch
recognition by MutS to repair (38). The interaction of hMutS
and hMutL proteins therefore plays a key role in the initiation
of the human repair reaction. However, little is known about
the precise contribution of the different ATPases or the protein
domains involved in this interaction.
We have previously established an assay using DNA-
coupled magnetic beads suitable to produce a speci®c, ATP-
and DNA-length-dependent complex between hMutSa and
hMutL heterodimers in protein extracts (27). It was the aim of
this study to extend this assay to allow investigation of
the protein properties contributing to this interaction.
More speci®cally, we assessed the role of ATP hydrolysis
by hMutLa in complex formation and evaluated the con-
tribution of the hMutL subunits hMLH1, hPMS1 and
hPMS2 to the interaction. For this aim, we over-expressed
hMutLa, hMutLb, the hMutL subunits hMLH1, hPMS1 and
hPMS2, as well as mutants of hMutLa and fragments of
hMLH1 in 293T cells. We demonstrate that ATP hydrolysis
by hMutLa is not necessary for complex formation, and
that the interaction is conferred by the N-terminus of
hMLH1, while the C-terminus is responsible for hMutL
heterodimerisation.
MATERIALS AND METHODS
Antibodies, reagents and cell lines
Poly(dI´dC) was purchased from Boehringer Mannheim
(Mannheim, Germany), and ATP from Sigma-Aldrich
(Steinheim, Germany). BamHI and EcoRI were from NEB
(Beverly, MA). Alkaline phosphatase was from Roche
(Mannheim, Germany). Anti-hMLH1 (G168-728) and anti-
hPMS2 (A16-4) were from Pharmingen (San Diego, CA).
Anti-hMSH2 (M34520) and anti-hMSH6 (G70220) were
purchased from Transduction Laboratories (Lexington, KY)
and anti-hMLH1 (Ab-1) from Oncogene (San Diego, CA). A
polyclonal hPMS1 antiserum (39) was kindly provided by Dr
Josef Jiricny (University of Zu Èrich, Switzerland). HeLa cells
were purchased from DMSZ (Braunschweig, Germany) and
grown in RPMI 1640 medium with 10% FCS. 293 and 293T
cells were grown in DMEM nut mix F-12 (HAM) with 10%
FCS. HCT-116 cells were kindly provided by Dr C. Richard
Boland (University of California, CA) and grown in DMEM
with 10% FCS. All oligonucleotides were purchased from
BioSpring (Frankfurt, Germany).
Expression vectors for hMLH1, hPMS2 and hPMS1
The pcDNA3.1 expression vector (Invitrogen, Carlsbad, CA)
containing the entire open reading frame of hMLH1 was a gift
of Dr Hong Zhang (Huntsman Cancer Institute, University of
Utah, Salt Lake City, UT). The pSG5 expression vector
(Stratagene, La Jolla, CA) containing full-length hPMS2
cDNA was provided by Dr Bert Vogelstein (Johns Hopkins
Oncology Center, Baltimore, MD). Nucleotide and amino acid
positions refer to the 2484 bp hMLH1 mRNA (GenBank
accession no. U07343.1) and the 756 amino acid hMLH1
sequence (GenBank accession no. AAC50285), respectively
(40). The expression vector for hPMS1 was generated by
cloning the full-length hPMS1 cDNA into pSG5. In short, total
RNA was extracted from human lymphocytes using the
TriStar reagent (Sigma, Steinheim, Germany). hPMS1 cDNA
was produced by reverse transcription with Superscript II
(Invitrogen) using the hPMS1-speci®c primer 5¢-gaacacactct-
catgtagtttc-3¢ and ampli®ed using the same primer together
with 5¢-gcaagctgctctgttaaaagcg-3¢. The PCR product was gel-
puri®ed and cloned into the pCR2.1 cloning vector
(Invitrogen). Escherichia coli K12 were transformed and
insert-carrying clones were analysed by sequencing. A clone
carrying the full-length human PMS1 cDNA corresponding to
the published sequence (GenBank accession no. NM_000534)
was digested with EcoRI. The insert was gel-puri®ed and
cloned into EcoRI-digested, dephosphorylated pSG5. A clone
carrying the correctly inserted cDNA was veri®ed by
sequencing.
Generation of vectors for expression of hMutLa ATPase
mutants and hMLH1 fragments
The hMutLa ATPase double mutant hMutLa-mpEA was
created by site-directed mutagenesis of the hMLH1 and
hPMS2 cDNAs (in pcDNA3.1 and pSG5, respectively). The
QuikChange Site-Directed Mutagenesis kit (Stratagene) was
used according to the manufacturer's instructions with the
following primer sets: 5¢-ccagctaatgctatcaaagcgatgattgagaac-
3¢ (sense) and 5¢-gttctcaatcatcgctttgatagcattagctgg-3¢ (anti-
sense) for hMLH1, and 5¢-gcactgcggtaaaggcgttagtagaaaa-
cagtc-3¢ (sense) and 5¢-gactgttttctactaacgcctttaccgcagtgc-3¢
(antisense) for hPMS2. hMLH1 fragments were generated by
PCR ampli®cation of the desired regions of the hMLH1
cDNA. Special primers were constructed to include BamHI
restriction sites on both ends of the PCR product as well as
start and stop codons in-frame with the new cDNAs. The
primers were as follows: 5¢-gtggatccatgtcgttcgtggcaggggttat-
3¢ and 5¢-gtggatcctcaactagtgaggttaatgatcc-3¢ for LN56, 5¢-
gtggatccatgagcatcctggagcgggtgcag-3¢ and 5¢-gtggatcctcaaca-
cctctcaaagactttgt-3¢ for LM42, and 5¢-gtggatccatggtagctgatgt-
taggacact-3¢ and 5¢-gtggatcctcaaaaattggcaaaatcataaa-3¢ for
LC49. After ampli®cation, the PCR products were puri®ed
and ligated into BamHI-digested, dephosphorylated pSG5.
Finally, all constructs were sequenced for veri®cation.
Transfection, extract preparation and
immunoprecipitation
293T cells were transfected using calcium phosphate precipi-
tation according to standard procedures (41). Brie¯y, 293T
cells were spread in 75 cm2 ¯asks to 70% con¯uency in 10 ml
of medium 24 h prior to transfection. The medium was
replaced 1 h before transfection. The suspension containing
the calcium phosphate±DNA precipitate (1 ml) was added to
the cell medium. After 5 h, the transfection medium was
replaced by fresh medium. Cells were harvested after 24 h and
whole cell extracts were prepared.
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PBS and resuspended in four times the packed cell volume of
hypotonic buffer [10 mM HEPES (pH 7.9), 5 mM MgCl2,
10 mM NaCl, 10 mM NaF, 0.1 mM EDTA, 0.5 mM PMSF,
0.5 mM DTT]. The suspension was frozen at ±80°C and
thawed on ice for lysis. This suspension containing both nuclei
and cytoplasmatic extract was supplemented with an identical
volume of hypertonic buffer [10 mM HEPES (pH 7.9), 5 mM
MgCl2, 830 mM NaCl, 10 mM NaF, 0.1 mM EDTA, 5 mM
PMSF,5mM DTT, 34%glycerol].Thesuspension wasrocked
on ice for 30 min and then centrifuged (4°C, 23 000 g). The
supernatant (whole cell extract) was aliquoted and stored at
±80°C. Expression of the desired protein was veri®ed by
western blotting in comparison to extracts of untransfected
293T cells (negative control) and extracts of 293 or TK6 cells
(expressing wild-type levels of MMR proteins) as a positive
control. Nuclear extracts were prepared from untransfected
293, HeLa, TK6 and HCT-116 cells as described previously
(27).
Immunoprecipitations were carried out in a total volume of
500 ml containing protein extract, 50 mM TE pH 8.0, 150 mM
NaCl, 1% Triton-X, 5 mM PMSF, 5 mM DTT and 1 mgo f
anti-hMLH1 G168-728 (Pharmingen). The incubation was
kept at 4°C for 1 h under agitation. Protein G agarose was
added and the suspension kept at 4°C for 3 h under agitation.
Supernatant was taken off and the agarose was washed three
times with 500 ml of washing buffer (50 mM TE pH 8.0,
150 mM NaCl, 1% Triton-X, 5 mM PMSF, 5 mM DTT).
Precipitated proteins were detached by boiling in sample
buffer for 5 min and analysed by western blotting.
DNA substrates and preparation of DNA-coupled
magnetic beads
The 81mer DNA substrates were produced as described
previously (27). Furthermore, a 200 bp homoduplex substrate
was used for this work. This substrate was generated by
ampli®cation of a 200 bp fragment of the human hPMS2
cDNA. One of the primers was 5¢-labelled with biotin to allow
binding to streptavidin-coupled beads. The following primers
were used: biotin-5¢-gcgagctgagagctcgagtac-3¢ (sense) and 5¢-
gaaacttcaataagatccactccatagtcc-3¢ (antisense). The ampli®cate
was puri®ed and coupled to Dynabeads streptavidin as
described (27). For every experiment, DNA-coupled beads
were produced in excess and aliquoted to ensure homogeneity
of all samples.
hMutSa±hMutL interaction assay
The hMutSa±hMutL interaction was assessed essentially as
described previously in the DNA binding assay (27). Brie¯y,
cell extract (150 mg protein) was incubated in 20 mM
Tris±HCl, pH 7.9, 50 mM NaCl, 1.5 mM MgCl2, 5% glycerol,
1 mM EDTA, 0.5 mM PMSF, 0.5 mM DTT and 1 mgo f
poly(dI´dC) in a total volume of 300 ml for 5 min at room
temperature. For investigation of hMutL constructs expressed
in 293T cells, 5 mg of this extract was diluted with 145 mgo f
HCT-116 nuclear extract. For each experiment, two identical
samples from one master mix were prepared. Both samples
were added to an aliquot of DNA-coupled beads and placed on
ice. All subsequent steps were performed on ice. After 20 min
incubation, ATP was added to one sample to produce a ®nal
concentration of 250 mM. After a further 5 min, the beads were
collected with a magnet and the supernatant was taken off. To
ensure complete removal of the supernatant, the cup was
brie¯y centrifuged, the beads were again collected and
residual buffer was taken off. The beads were then
resuspended in 20 ml of elution buffer (700 mM NaCl,
20 mM Tris±HCl, pH 7.9, 1.5 mM MgCl2, 5% glycerol, 1 mM
EDTA, 0.5 mM PMSF and 0.5 mM DTT) and incubated for
5 min. The beads were collected and the supernatant stored for
analysis. A second elution step was performed with 20 mlo f
elution buffer as above, only with 1000 mM NaCl. This
elution was also analysed by western blotting and veri®ed that
ATP had taken effect, since it abolished hMutSa signals in
this elution fraction (27). Although this elution was always
performed as a control, these data have been omitted in most
®gures. This assay produced a 2±3-fold increase in binding of
hMutL heterodimers after ATP addition as evaluated by
densitometric analysis.
Western blotting
The proteins were separated on 10 or 12.5% polyacrylamide
gels, followed by western blotting on nitrocellulose
membranes and antibody detection using standard procedures.
hMLH1 was detected with Pharmingen G168-728 except for
the blot shown in Figure 8 (top), which was detected with
Oncogene Ab-1. Densitometric evaluation of the western blots
was performed with GelScan 5.0 Software (BioSciTec,
Frankfurt, Germany).
RESULTS
200mer homoduplex DNA improves detection of the
speci®c complex of hMutLa with hMutSa
We have previously demonstrated that hMutLa and hMutLb
bind to DNA substrates coupled to magnetic beads in an ATP-
dependent manner only when hMutSa is present (27). This
binding therefore represents a speci®c complex of hMutLa
and hMutLb with hMutSa on DNA. This interaction is
improved when substrate length is increased from the
previously used 81mer DNA substrate to 200mer DNA. The
longer DNA substrate is more ef®cient in retaining hMutSa in
the presence of ATP and also recruits hMLH1 more ef®ciently
(Fig. 1). The 200mer homoduplex therefore supports complex
formation of hMutSa and hMutL proteins better than the
81mer homoduplex, which is in agreement with previous
®ndings showing that the interaction depends on DNA length
and improves on longer substrates (27,30).
The hMutSa±hMutL interaction does not depend on
mismatched base pairs in this assay (27). Therefore, homo-
duplex DNA is suitable for the measurement of this
interaction, though it is not the substrate of the repair reaction
(see Discussion). Since homoduplexes are more easily gen-
erated and produced identical results as heteroduplexes in this
assay whenever tested, we used the 200mer homoduplex in
most of the following experiments. In cases when a contri-
bution of mismatched base pairs to complex formation was
possible, we performed additional experiments with hetero-
duplex substrates in parallel (see below).
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hMutSa can be assessed with HCT-116 nuclear extract
293T cells are de®cient in heteroduplex repair because of the
lack of hMutLa, which is not expressed due to hMLH1
promoter methylation (42). Transfection of hMutLa restores
MMR activity of 293T extracts, which has been utilised to
study the effect of HNPCC-associated genetic changes of
hMLH1 on the MMR status in vitro (42). Since the concen-
tration of hMutLa in extracts of transfected 293T cells
drastically exceeds the biological concentration of this
heterodimer observable in HeLa or TK6 extracts (Fig. 2),
we diluted them with HCT-116 nuclear extract to reduce the
hMutLa concentration to biological levels. HCT-116 cells are
also de®cient in hMutL proteins, and the interaction assay
works well with this extract when hMutLa is supplemented
(27). This procedure produced a 2±3-fold increase in binding
of recominant hMutLa, which is comparable to the recruit-
ment of endogenous hMutLa in HeLa extracts (Fig. 3). This
approach therefore allows expression of any desired hMutL
construct in 293T cells with subsequent examination of its
interaction properties with hMutSa.
ATP hydrolysis by hMutLa is not necessary for
interaction
The presence of ATP is necessary for recruitment of hMutLa
by hMutSa (27,31±34,43). Both hMutLa and hMutSa are
ATPases. This raises the question of which protein needs to
bind or process ATP to start the interaction. The ATP
concentration effecting hMutSa±hMutL complex formation is
identical to the ATP concentration altering DNA binding of
hMutSa [1±10 mM (27)], suggesting a concerted process. It
cannot be excluded, however, that the hMutL ATPase may
also contribute to complex formation. To investigate whether
hMutLa needs to hydrolyse ATP to join hMutSa,w e
generated a hMutLa mutant (designated hMutLa-mpEA)
with one amino acid exchange in the ATPase domains of each
of its subunits hMLH1 and hPMS2. Both exchanges (hMLH1
E34A and hPMS2 E41A) alter a conserved glutamate, which
is homologous to E.coli MutL E29, to alanine. This glutamate
positions a water molecule for a nucleophile attack on the g-
phosphate of ATP, thus catalysing ATP hydrolysis (44). The
mutation to alanine abolishes ATP hydrolysis of MutL
proteins and MMR in bacteria, yeast and humans (26,31,33).
Nevertheless, hMutLa-mpEA and its yeast homologue
showed the same ATP-induced conformational changes as
Figure 1. Complex formation of hMutLa with hMutSa on 200mer and
81mer DNA substrates. HeLa nuclear extract (150 mg) was incubated with
200mer or 81mer homoduplex DNA coupled to magnetic beads according
to the hMutSa±hMutL interaction assay described in Materials and
Methods. For each DNA substrate, two identical incubations were per-
formed for 20 min. Then, ATP (250 mM ®nal concentration) was added to
one of the two mixtures (signi®ed by `+'), and incubations were continued
for 5 min. The supernatant of the DNA beads was removed and proteins
bound to the substrates were eluted in two fractions, ®rst with 700 mM
NaCl (top), then with 1000 mM NaCl (bottom). Both elutions were separ-
ated on 10% polyacrylamide gels and blotted. hMSH2, hMSH6 and hMLH1
were detected using speci®c antibodies. The 700 mM NaCl fraction quanti-
tatively elutes hMLH1 and its partner proteins hPMS1 and hPMS2
(hMutLa and hMutLb) (27), while both fractions together elute hMutSa
quantitatively. The ATP-dependent recruitment of hMLH1 to the DNA sub-
strate becomes visible in the 700 mM fraction. The 1000 mM NaCl fraction
serves as control that ATP has taken effect, since this nucleotide abolishes
the hMutSa signal in this elution fraction (27).
Figure 2. Expression of hMutLa, hMutLb, hMLH1, hPMS1 and hPMS2 in
293T cells. 293T cells were either cotransfected with hMLH1-hPMS2
(hMutLa) or hMLH1-hPMS1 (hMutLb) or transfected with hMLH1,
hPMS2 or hPMS1 as described in Materials and Methods. Extracts were
prepared according to the protocol in Materials and Methods and 50 mgo f
total protein were separated on a 10% polyacrylamide gel. For comparison,
a5 0mg extract of the MMR pro®cient cell line TK6 was analysed in
parallel. hMLH1, hMSH2, hMSH6 (top), hPMS1 (middle) and hPMS2
(bottom, upper signal; the lower signal is hMSH2) were detected using
speci®c antibodies. The signals of hMutSa (hMSH2 and hMSH6) serve as a
loading control.
Figure 3. Interaction of hMutLa expressed in 293T cells with hMutSa can
be assessed with HCT-116 nuclear extract. The hMutSa±hMutL interaction
assay was performed with magnetic beads coupled with 200 bp homoduplex
DNA according to the procedure described in Figure 1 and Materials and
Methods. Left: the beads were incubated with nuclear extracts of HeLa cells
(150 mg). Right: the DNA beads were incubated with a nuclear extract of
the hMutL-de®cient cell line HCT-116 (150 mg), or with a combination of
HCT-116 extract (145 mg) with a 5 mg extract of 293T cells transfected
with hMutLa. In all cases, ATP (250 mM ®nal concentration) was added to
one of two identical samples prior to elution (signi®ed by `+'). Bound
proteins were eluted from the DNA beads with 700 and 1000 mM NaCl.
The western blot of hMutSa and hMLH1 of the 700 mM elution fraction is
shown.
3220 Nucleic Acids Research, 2003, Vol.31, No.12the wild-type protein in proteolysis experiments (26,31),
demonstrating that the mutations do not attenuate ATP
binding and its conformational effects. Furthermore, no
reduction of expression and dimerisation was observed in
these studies.
hMutLa-mpEA was over-expressed in 293T cells, and
expression levels were similar to those of wild-type hMutLa
(Fig. 4A). The ATPase mutant interacted as ef®ciently with
hMutSa as wild-type hMutLa (Fig. 4B), con®rming that ATP
hydrolysis by hMutLa is not necessary for ternary complex
formation.
hMutSa can recruit both hMutLa and hMutLb
independently
Both hMutLa and hMutLb are recruited to the DNA by
hMutSa after addition of ATP (27). To assess whether both
heterodimers can be recruited only together or also bind
individually, we transfected them separately into 293T cells.
Both were strongly expressed (Fig. 2, lanes 2 and 3). No
hPMS2 was detectable in hMutLb-transfected cells, while no
hPMS1 was detectable in hMutLa-transfected cells, excluding
contaminations with the respective hPMS partners. Both
hMutL heterodimers interacted ef®ciently with hMutSa in the
assay even when used individually (Fig. 5, lanes 1±4).
Furthermore, a mixture of both hMutLa and hMutLb did
not further improve complex formation either (Fig. 5, lanes 5
and 6), suggesting that binding does not show cooperative
effects.
hMLH1 is predominantly responsible for hMutL-
hMutSa interaction
The binding of hMutLa and hMutLb to hMutSa may be
conferred either by one of the hMutL-heterodimer subunits
alone or by concerted binding of bothsubunitssimultaneously.
To assess which hMutL subunits establish the interaction, we
expressed and examined hMLH1, hPMS1 and hPMS2 indi-
vidually. hMLH1 was as strongly expressed as when
transfected with its heterodimeric partners (hMutLa or
hMutLb, Fig. 2). While no hPMS2 was detectable in the
extract of hMLH1-transfected cells, a weak co-expression of
hPMS1 was observed (Fig. 2, lane 4, middle). Since hMLH1
has been shown to stabilise its heterodimeric partner proteins
(39,45±47), this co-expression likely results from stabilisation
of endogenous hPMS1.
Although unquestionable evidence exists that neither
hPMS1 nor hPMS2 are stable in the absence of their
heterodimeric counterpart hMLH1 (see Discussion), we
successfully expressed both subunits to high concentrations
in 293T cells (Fig. 2, lanes 5 and 6). Neither extract contained
hMLH1.
Performance of the interaction assay with these three
individual hMutL subunits revealed that hMLH1 interacted
ef®ciently with hMutSa (Fig. 6A, lanes 1 and 2). In contrast,
hPMS1 and hPMS2 showed much weaker basic binding and a
signi®cantly attenuated ATP-promoted complex formation
with hMutSa (Fig. 6A, lanes 3 and 4, 7 and 8). Furthermore,
supplementation of hMLH1 restored hPMS2 binding activity
as well as its full ATP reactivity (Fig. 6A, bottom, lanes 5 and
6 versus 3 and 4). To exclude that the use of homoduplex DNA
instead of a mismatched substrate caused the weak reaction of
hPMS2, we compared its interaction with hMutSa on 81mer
homoduplex versus heteroduplex DNA. hMutSa showed
improved binding to the heteroduplex in the absence of ATP
in the 1000 mM elution fraction (Fig. 6B, bottom) as reported
previously (27). Although hMutSa therefore clearly reacted to
the presence of the mismatch, no difference in hPMS2
recruitment between homo- and heteroduplex substrates was
detectable (Fig. 6B, middle).
Only the N-terminus of hMLH1 confers interaction with
hMutSa
Based on the ®nding that the interaction of hMutL proteins
with hMutSa is predominantly conferred by hMLH1, we
Figure 4. Expression of hMutLa-mpEA and interaction with hMutSa.
(A) hMLH1-hPMS2 (hMutLa) or hMLH1 E34A-hPMS2 E41A (hMutLa-
mpEA) were cotransfected into 293T cells. Protein extracts of the trans-
fected cells and, for comparison, extract of the MMR pro®cient cell line
TK6 (50 mg each) were separated in a 10% polyacrylamide gel and blotted.
hMSH6, hMSH2, hMLH1 and hPMS2 were detected using speci®c anti-
bodies. The signals of hMutSa (hMSH2 and hMSH6) serve as a loading
control. (B) The hMutSa±hMutL interaction assay was performed with
magnetic beads coupled with 200 bp homoduplex DNA according to the
procedure described in Figure 1 and Materials and Methods. The beads
were incubated with 145 mg of nuclear extract of HCT-116 cells supple-
mented with a 5 mg extract of 293T cells expressing either wild-type
hMutLa or hMutLa-mpEA from the transfection displayed in (A). ATP
(250 mM ®nal concentration) was added to one of two identical samples
prior to elution (signi®ed by `+'). The western blots of hMSH6, hMSH2,
hMLH1 and hPMS2 of the 700 mM NaCl elution fraction are shown.
Figure 5. Interaction of hMutLa and hMutLb with hMutSa. The
hMutSa±hMutL interaction assay was performed according to Figure 1 and
the protocol described in Materials and Methods with magnetic beads
coupled with 200 bp homoduplex DNA. Incubations were performed with a
nuclear extract of HCT-116 cells (145 mg) supplemented with a 5 mg extract
of 293T cells transfected with hMutLa (lanes 1 and 2), hMutLb (lanes 3
and 4) or with 2.5 mg of each extract (lanes 5 and 6) from the transfection
displayed in Figure 2. ATP (250 mM ®nal concentration) was added to one
of two identical samples prior to elution (signi®ed by `+'). The western
blots of hMSH6, hMSH2, hMLH1, hPMS1 and hPMS2 of the 700 mM
NaCl elution fraction are shown.
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which protein domains are essential for interaction. Three
fragments of the hMLH1 cDNA, each containing start and stop
codons, were produced and cloned into the pSG5 expression
vector. The N-terminal cDNA fragment (LN56) covers amino
acids 1±505, the centrally located fragment (LM42) covers
amino acids 201±571, while the C-terminal fragment (LC49)
included amino acids 321±756. They correspond to proteins of
calculated molecular weights of 56, 42 and 49 kDa, respect-
ively.
All three constructs were transfected into 293T cells, but
only LN56 and LC49 were strongly expressed (Fig. 7). LM42
could not be detected by western blotting with two different
monoclonal antibodies (data not shown). Since both anti-
bodies readily detected LN56 as well as LC49, both must
recognise epitopes located in the centre of hMLH1, excluding
a pure detection failure. In contrast to extracts of cells
transfected with hMLH1, those with LN56 or LC49 did not
contain detectable amounts of hPMS1 or hPMS2 (data not
shown).
Co-expression of LN56 or LC49 with hPMS2 showed that
LC49 supportedexpressionofhPMS2morethanLN56(Fig.8,
middle). Furthermore, only hMLH1 and LC49, but not LN56,
were able to co-immunoprecipitate hPMS2 (Fig. 8, bottom),
proving that the domain for heterodimerisation with hPMS2 is
lost in LN56.
While hMutSa recruited LN56 very ef®ciently to the DNA
substrate, neither basic binding nor ATP-dependent recruit-
ment were detectable with LC49 (Fig. 9B, lanes 1±4). Testing
the interaction of the LC49-hPMS2 heterodimer showed that
LC49 did not support hPMS2 recruitment (or vice versa),
underlining that neither hPMS2 nor the C-terminal part of
hMLH1 contain domains ef®ciently supporting interaction
with hMutSa (Fig. 9B, lanes 3±8). Since LN56 did not
heterodimerise with hPMS2, we did not test the interaction
properties of this cotransfection.
A hMLH1 deletion mutant does not interact with
hMutSa
hMLH1D9/10 is a hMLH1 mutant which has lost exons 9 and
10, leading to an in-frame deletion of 210 bp (70 amino acids)
in the ATPase domain (amino acids 227±296). This mutant
has been described to be associated with HNPCC (48±50), but
has also been found as a common splicing variant in healthy
volunteers (51,52), which raised the question of its
Figure 6. Interaction of hMutL subunits with hMutSa.( A) The hMutSa±hMutL interaction assay was performed with magnetic beads coupled with 200 bp
homoduplex DNA according to the procedure described in Figure 1 and Materials and Methods. The beads were incubated with 145 mg of nuclear extract of
HCT-116 cells supplemented with a 5 mg extract of 293T cells expressing either hMLH1, hPMS2 or hPMS1 from the transfection displayed in Figure 2. In
one case, the HCT-116 extract was supplemented with two extracts of 293T cells, one prepared from cells transfected with hMLH1, the other from cells
transfected with hPMS2 (2.5 mg each). ATP (250 mM ®nal concentration) was added to one of two identical samples prior to elution (signi®ed by `+'). The
western blots of hMSH6, hMSH2, hMLH1, hPMS1 and hPMS2 of the 700 mM NaCl elution fraction are shown. (B) The hMutSa±hMutL interaction assay
was performed with a nuclear extract of HCT-116 (145 mg) supplemented with an extract of 293T cells transfected with hPMS2 (5 mg) according to the
procedure described in Figure 1 and the protocol in Materials and Methods. DNA beads coupled with 81mer duplexes were used that were either correctly
paired (GC) or contained a mismatch (GT). ATP (250 mM ®nal concentration) was added to one of two identical samples (signi®ed by `+') prior to elution.
The western blots of hMSH6, hMSH2 and hPMS2 of the 700 mM NaCl elution fraction are shown. Furthermore, the western blot of hMSH6 and hMSH2 of
the 1000 mM NaCl elution fraction is shown to demonstrate that the presence of a mismatch actually affected hMutSa binding: the mismatch confers a
greater elution resistance to hMutSa in the absence of ATP, resulting in increased signals of hMSH2 and hMSH6 on heteroduplex compared to homoduplex
(third lane versus ®rst lane). For detailed characterisation of this effect, see Plotz et al. (27).
Figure 7. Expression of hMLH1 fragments in 293T cells. 293T cells were
transfected or cotransfected with either hMLH1-hPMS2 (hMutLa), LN56 or
LC49. Extracts were prepared according to the protocol in Materials and
Methods. Fifty micrograms of total protein were separated on a 12.5%
polyacrylamide gel. For comparison, a 50 mg extract of the MMR pro®cient
cell line TK6 was analysed in parallel. hMLH1, hMSH2 and hMSH6 were
detected using speci®c antibodies. The hMLH1 antibody also recognised the
hMLH1 fragments LN56 (56 kDa) and LC49 (49 kDa). The signals of
hMutSa (hMSH2 and hMSH6) serve as a loading control. The non-speci®c
bands visible between 37 and 50 kDa in the extracts of cells transfected
with hMutLa (and also, to some degree, in the transfections with LC49)
most likely represent degradation products of these proteins.
3222 Nucleic Acids Research, 2003, Vol.31, No.12pathogenicity. We have recently shown that this mutant is
de®cient in strand-speci®c MMR (42). Expression resulted in
an hMLH1 protein of the expected lower molecular mass
(Fig. 10A). This deletion mutant showed only very weak basic
binding in the hMutSa±hMutL interaction assay, and did not
react to ATP addition (Fig. 10B). Analogous to the experiment
shown in Figure 6B, we veri®ed that interaction of hMutLa
D9/10 indeed failed on heteroduplex substrates as well as
homoduplex substrates (data not shown). This ®nding demon-
strates that MMR fails at the early step of complex formation
with hMutLaD 9/10.
DISCUSSION
The experimental investigation of the hMutSa±hMutL inter-
action is challenging since it only occurs under certain
conditions (in the presence of ATP and a DNA duplex
substrate of suf®cient length). This restricts the use of classical
approaches for protein interaction measurement like co-
immunoprecipitation or GST fusion protein pulldown assays.
For detailed characterisation of the interaction, it is most
promising to capture hMutSa±hMutL complexes on the
matrix on which they form, the DNA. This has been attempted
in several systems with bacterial, yeast and human proteins
using either gel retardation assays or surface plasmon
resonance spectroscopy (24,27,30,31,53±55). In the present
work, we show that a novel DNA binding assay we recently
used for proving that hMutSa interacts with hMutLa and
hMutLb (27) can be extended to investigate the interaction
properties of diverse hMutL constructs expressed in 293T
cells, providing a ¯exible tool for detailed characterisation of
this interaction.
Both homoduplex and heteroduplex substrates ef®ciently
support interaction in this assay, therefore binding to a
mismatch was not a precondition for complex formation under
the applied experimental conditions. The complexes arising on
homoduplex DNA should not be competent to initiate repair
since they have not detected a mismatched site. However,
since no difference could be detected between complex
formation on faulty and correct DNA substrates, interaction
between hMutSa and hMutL proteins may either be possible
independently of the type of DNA substrate or hMutSa is
(under the experimental conditions used) transferred arti®-
cially into a mode it can biologically only assume after
encountering a mismatch. Either way, the use of homoduplex
substrates does not ¯aw the general applicability of the assay
for the examination of complex formation.
ATP hydrolysis is necessary for the processing of faulty
DNA by MMR proteins, and MutL ATPase mutants
de®cient in ATP hydrolysis are defective in strand-speci®c
MMR of bacteria, yeast and humans (26,31±34). However, the
Figure 8. Expression and co-immunoprecipitation of hPMS2 with hMLH1
fragments. Top: Transfection scheme for cotransfection of 293T cells with
hMLH1-hPMS2 (hMutLa), LN56-hPMS2 or LC49-hPMS2. Middle: protein
extracts of these transfections were prepared and 50 mg were separated on a
12.5% polyacrylamide gel, followed by western blotting and detection of
hMLH1 and hPMS2. Bottom: an immunoprecipitation was performed
according to the protocol described in Materials and Methods with an
antibody against hMLH1 (G168-728; Pharmingen) using 100 mg of the
hMLH1-hPMS2 and LC49-hPMS2 extracts, respectively, and 200 mg of the
LN56-hPMS2 extract to adjust the experiment to the different expression
levels of the proteins. For one experiment, the extract containing hMutLa
was used, while the antibody was omitted as a control for successful
washing (data not shown). The western blot of the precipitates is shown
(hMLH1 and hPMS2 were detected). A, non-speci®c signals from
degradation products and the immunoprecipitating antibody.
Figure 9. Interaction of hMLH1 fragments with hMutSa. The
hMutSa±hMutL interaction assay was performed with magnetic beads
coupled with 200 bp homoduplex DNA according to the procedure
described in Figure 1 and Materials and Methods. The beads were incubated
with 145 mg of nuclear extract of HCT-116 cells supplemented with a 5 mg
extract of 293T cells transfected with LN56, LC49, hPMS2 or
LC49-hPMS2 from the transfection displayed in Figures 7 and 8. ATP
(250 mM ®nal concentration) was added to one of two identical samples
prior to elution (signi®ed by `+'). (A) Western blot of the original
incubation mixtures of this experiment showing the presence and adequate
concentration of the hMutL constructs in the samples. (B) Western blots of
hMSH6, hMSH2, hMLH1 and hPMS2 of the 700 mM NaCl elution fraction
are shown.
Nucleic Acids Research, 2003, Vol.31, No.12 3223hMutSa±hMutLa interaction occurred under conditions
which do not favour ATP hydrolysis (incubations on ice and
at relatively low concentration of Mg2+). Furthermore, the
interaction is not attenuated by the well characterised point
mutation of hMutLa-mpEA, which blocks ATP hydrolysis of
hMutLa. This suggests that ATP hydrolysis by hMutLa
occurs downstream of the assembly of hMutSa and hMutLa
on DNA. This ®nding supports previous experiments per-
formed with puri®ed proteins and gel-shift assays (31). The
possibility that binding of ATP by hMutLa (without
hydrolysis) is a precondition of complex formation, however,
cannot be excluded by these experiments.
Extensive evidence proves that neither hMSH6/hMSH3 nor
hPMS1/hPMS2 are stable in the absence of their respective
smaller heterodimeric partners hMSH2 and hMLH1
(39,45±47). This is also illustrated by the observation that
cell lines lacking hMSH2 or hMLH1 do not show signi®cant
protein levels of hMSH6/hMSH3 or hPMS1/hPMS2 either,
even if their genes do not carry mutations. Consequently, we
did not expect that transfection of hPMS1 or hPMS2 would
yield suf®cient protein for further investigations. To our
surprise, a high expression of both subunits was achieved in
our experiments. This was not attributable to a general
stability of hPMS1 and hPMS2 in 293T cells, since this cell
line also lacks endogenous hPMS proteins due to the absence
of hMLH1. Rather, we assume that the degradation of hPMS
proteins was not ef®cient enough to compete with the strong
expression of the subunits in 293T cells after transfection.
Nevertheless, hMLH1 exerted a stabilising effect, which
became obvious when hPMS2 protein levels were compared
in extracts of cells cotransfected either with the N-terminal or
the C-terminal part of hMLH1. LC49 exhibited a stabilising
effect and could co-precipitate hPMS2, which was not
possible with LN56. The results demonstrate that the
dimerisation domain of hMLH1 is located within its C-
terminus, and that dimerisation with hMLH1 confers stability
to hPMS2, con®rming previous studies (56,57).
The individual expression of all hMutL subunits further
enabled the investigation of their contributions to interaction
with hMutSa. Since hMutSa and hMutLa interact not only in
cell extracts, but also when used puri®ed (27,30,31), it can be
concluded that the interaction is accomplished through a direct
contact between both heterodimers. Only hMLH1 ef®ciently
joined hMutSa on DNA in an ATP-dependent manner,
demonstrating that hMLH1 predominantly confers this inter-
action. Although our hMLH1 preparation contained a small
amount of hPMS1, it was not hMutLb that produced this
result, since hPMS1-free preparations of the N-terminal
hMLH1-fragment LN56 also interacted (see below).
One caveat must be considered in the interpretation of these
results: since both hPMS proteins were expressed in the
absence of their stabilising partner hMLH1, misfolding may
underlie the failure to accomplish interaction with hMutSa.
Two important observations, however, disfavour this possi-
bility. First, we expressed hPMS2 in the presence LC49,
which conferred stabilisation of hPMS2. Although hPMS2
should therefore be correctly folded in LC49-hPMS2, this
heterodimer was unable to interact ef®ciently with hMutSa
either. Secondly, when hPMS2 was complemented with
hMLH1, the reactivity of hPMS2 was fully restored: hPMS2
was folded correctly enough to re-establish an interacting
hMutLa heterodimer with hMLH1. One can therefore state
that the interaction of hMutSa with hMutL heterodimers is
predominantly conferred by hMLH1. Nevertheless, the ®nd-
ing that the hPMS subunits have a very weak interacting
ability suggests that PMS1 and PMS2 contact hMutSa once
the complex has been established by hMLH1.
The examination of hMLH1 fragments revealed that its N-
terminus is suf®cient for interaction with hMutSa (Fig. 11).
Based on considerations of crystal structures of MutL, the area
between the loops L45 has been suggested to serve as
interaction interface for MutS (Fig. 11) (44). The ®nding that
hMLH1D9/10 fails to interact suggests that exons 9 and 10
may incorporate a domain essential for complex formation.
Although this deletion is distant from the loops that are
Figure 10. Expression of hMutLaD 9/10 and interaction with hMutSa.
(A) 293T cells were cotransfected either with hMLH1-hPMS2 (hMutLa)o r
hMLH1D9/10-hPMS1 (hMutLaD 9/10) as described in Materials and
Methods. Extracts prepared according to the protocol in Materials and
Methods were separated on a 10% polyacrylamide gel (50 mg of total
protein in each lane) and blotted. For comparison, a 50 mg extract of the
MMR pro®cient cell line TK6 was analysed in parallel. hMLH1 and hPMS2
were detected using speci®c antibodies. (B) The hMutSa±hMutL interaction
assay was performed with magnetic beads coupled with 200 bp homoduplex
DNA according to the procedure described in Figure 1 and Materials and
Methods. The beads were incubated with nuclear extracts of HCT-116 cells
(145 mg) supplemented with a 5 mg extract of 293T cells transfected either
with wild-type hMutLa or with hMutLaD9/10 from the transfection dis-
played in (A). ATP (250 mM ®nal concentration) was added to one of two
identical samples prior to elution (signi®ed by `+'), and bound proteins
were eluted from the DNA beads. The western blots of hMSH2, hMSH6,
hMLH1 and hPMS2 of the 700 mM elution fraction are shown.
Figure 11. Diagram of the hMLH1 constructs. In the top diagram, the
hMLH1 protein is shown with its functional domains as known to date.
Numbers refer to amino acid positions. hMLH1 encodes a protein of 756
amino acids including a highly conserved N-terminal ATPase domain
(`ATPase domain') as well as a variant C-terminal domain (`PMS
interaction domain'), which has been suggested to confer dimerisation with
hPMS1 and hPMS2 (56). The ATPase domain also incorporates the
conserved loops L45, which have been suggested to contain the
MutS±MutL interaction interface in bacterial MMR (44). The diagrams
below show the localisation of the hMLH1 fragments LN56 and LC49 as
well as the hMLH1 D9/10 protein in comparison to the full-length protein.
Right: +, interaction; ±, no interaction.
3224 Nucleic Acids Research, 2003, Vol.31, No.12homologous to L45, it does not disqualify this area as
interaction transmitter, since it was also observed that
formation of this interface depends on both nucleotide binding
and N-terminal dimerisation (44). Both functions are likely
abolished in hMLH1D9/10.
Since the N-terminus incorporates the ATPase domain as
well as the hMutSa±hMutLa interaction domain, it is possible
that the interaction may alter ATP processing by hMutLa,
thus accomplishing signal transduction from hMutSa over
hMutLa to downstream proteins.
If it is true that interaction and ATP processing of hMutLa
are closely coupled, deletions in the ATPase domain may
abolish interaction even while a putative interaction interface
still is present. Another aspect complicates the precise
localisation of the interacting region: as recently shown, the
hMutSa±hMutL interaction is DNA length dependent and
fails on short DNA substrates (27,30,31). Additionally, MutL
proteins bind single- and double-stranded DNA (27,28,58) and
contain putative DNA binding domains within their
N-terminal halves (25,44). This is supported by our ®nding
that LC49 did not show even basic binding to the DNA
substrate. These observations strongly suggest that
hMutSa±hMutLa interaction depends on DNA binding by
hMutLa (27,30). Assuming that DNA binding by hMutLa is a
precondition for complex formation, mutational inactivation
of either the interaction interface or the DNA binding activity
may result in an interaction failure. Further studies will be
necessary to disentangle the mutual in¯uences of hMLH1
domains concerned with DNA binding, ATP processing and
hMutSa interaction.
We have recently demonstrated that both hMutLa and
hMutLb interact with hMutSa on DNA in an ATP-dependent
manner (27). hMutLb could not be attributed with a role in
in vitro MMR (39), and its putative contribution to HNPCC
(59) has recently been refuted (60). The ®ndings of the present
study show that hMutSa nonetheless strongly recruits hMutLb
in the absence of hMutLa. Furthermore, hPMS1 has an
intrinsic ability to bind hMutSa (which is, although being
much weaker than that of hMLH1, stronger than that of
hPMS2), suggesting a biological signi®cance of this inter-
action. When both hMutL heterodimers are present, they may
either together form quaternary complexes with hMutSa and
DNA or distinct ternary complexes. Since both hMutL
heterodimers bind predominantly by their hMLH1 subunit, it
is likely that both heterodimers compete for binding to
hMutSa. Further studies need to examine how many hMLH1
binding sites the hMutSa heterodimer has.
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